trending Market Intelligence /marketintelligence/en/news-insights/trending/fX-RT6pytY1bnT9Nf_jaqw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Sun Pharmaceutical recalls injectible muscle relaxer with glass impurities

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sun Pharmaceutical recalls injectible muscle relaxer with glass impurities

India's Sun Pharmaceutical Industries Ltd. is recalling four lots of injectible Norcuron from hospitals due to the presence of extremely small glass particles in the medicine.

Norcuron, or vecuronium bromide, is used as part of general anesthesia to relax muscles before surgery or mechanical ventilation.

The company has recalled three lots of the medication in 10-milligram dosage and one lot in the 20-milligram dosage.

Injecting glass particles with other medication can lead to irritation and swelling and in extreme cases may cause blockage and clotting in blood vessels, which can be life-threatening.

The company said it has not received any reports of adverse events related to the recall, which is being conducted with the knowledge of the U.S. Food and Drug Administration.